Trial Profile
The changes in creatinine and cystatin C-based estimated GFR values before and after dolutegravir initiation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Apr 2018
Price :
$35
*
At a glance
- Drugs Dolutegravir (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 27 Apr 2018 New trial record
- 24 Apr 2018 Results published in the Journal of Antimicrobial Chemotherapy